EP Patent

EP2745692A1 — anti-fungal formulation containing luliconazole

Assigned to Tinea Pharmaceuticals Inc · Expires 2014-06-25 · 12y expired

What this patent protects

Provided herein are compositions and formulations comprising an antifungal agent. Pharmaceutical compositions comprising luliconazole in an amount effective for the treatment of onychomycosis are provided. Also provided are methods for treating dermatomycoses and onychomycosis us…

USPTO Abstract

Provided herein are compositions and formulations comprising an antifungal agent. Pharmaceutical compositions comprising luliconazole in an amount effective for the treatment of onychomycosis are provided. Also provided are methods for treating dermatomycoses and onychomycosis using the compositions and formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP2745692A1
Jurisdiction
EP
Classification
—
Expires
2014-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Tinea Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.